Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B with Nucleoside (Nucleotide) Analog-Experienced Resulting in Hepatitis B Surface Antigen Clearance: A Case Report
Viral Immunology · 01.02.2022 · 35 (1) · 71-75
DOI: 10.1089/vim.2021.0112 ↗Kurz gefasst
Fallbericht in der Zeitschrift Viral Immunology, erschienen am 01.02.2022. Verfasst von Yan-Jie Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B, Chronic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China.
- Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Yan-Jie Lin, Ming-Hui Li, Yao Xie
Zitieren
APA
Lin, Y. J., Sun, F. F., Zeng, Z., Bi, X. Y., Yang, L., Li, M. H., & Xie, Y. (2022). Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B with Nucleoside (Nucleotide) Analog-Experienced Resulting in Hepatitis B Surface Antigen Clearance: A Case Report. Viral Immunology, 35(1), 71-75. https://doi.org/10.1089/vim.2021.0112
Vancouver
Lin YJ, Sun FF, Zeng Z, Bi XY, Yang L, Li MH, et al. Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B with Nucleoside (Nucleotide) Analog-Experienced Resulting in Hepatitis B Surface Antigen Clearance: A Case Report. Viral Immunology. 2022;35(1):71-75. doi:10.1089/vim.2021.0112
BibTeX
@article{Lin2022,
author = {Lin, Yan-Jie and Sun, Fang-Fang and Zeng, Zhan and Bi, Xiao-Yue and Yang, Liu and Li, Ming-Hui and Xie, Yao},
title = {Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B with Nucleoside (Nucleotide) Analog-Experienced Resulting in Hepatitis B Surface Antigen Clearance: A Case Report},
journal = {Viral Immunology},
year = {2022},
volume = {35},
number = {1},
pages = {71--75},
doi = {10.1089/vim.2021.0112}
}
EUVIMED